Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy
H PaiKang-Won Choe

Abstract

Cases of bacteremia caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae isolates were retrospectively studied to determine the epidemiologic features and clinical outcomes of bloodstream infections. Among 389 blood isolates recovered from 1998 to 2002, 65 isolates (16.7%) were found to be extended-spectrum beta-lactamase (ESBL) or AmpC beta-lactamase producers. The beta-lactamases from 61 of the 65 isolates were characterized; 28 of 61 isolates produced AmpC-type enzymes (14 isolates each produced DHA-1 and CMY-1-like enzymes), 32 isolates produced TEM or SHV-related ESBLs, and 1 isolate produced a CTX-M-14-like enzyme. To compare the clinical features and outcomes of bloodstream infections caused by AmpC producers with those caused by TEM- or SHV-related ESBL producers, 27 patients infected with isolates producing AmpC-type enzymes (AmpC group) and 25 patients infected with isolates producing TEM- or SHV-related enzymes (ESBL group) were analyzed. There was no significant difference between the AmpC and the ESBL groups in terms of risk factors. When the initial response was assessed at 72 h after antimicrobial therapy, the treatment failure rate for the AmpC group was 51.9% (14 of 27 patients) and the 7- and 30-...Continue Reading

References

Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Jul 2, 1999·Antimicrobial Agents and Chemotherapy·L Martínez-MartínezG A Jacoby
Apr 3, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E LautenbachN O Fishman
Apr 11, 2001·Emerging Infectious Diseases·K S Thomson
Jun 23, 2001·The Journal of Antimicrobial Chemotherapy·D M Livermore, D F Brown
Dec 26, 2001·Antimicrobial Agents and Chemotherapy·Alain PhilipponGeorge A Jacoby

❮ Previous
Next ❯

Citations

May 3, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W-Y SuJ Merlino
Jan 3, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y MatsumuraS Ichiyama
Jan 28, 2005·The New England Journal of Medicine·George A Jacoby, Luisa Silvia Munoz-Price
Jul 14, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Joanna EmpelMarek Gniadkowski
Mar 8, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Wing Sze HoKwai Lin Thong
Jan 8, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Bao-Tao LiuYa-Hong Liu
Jun 14, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pranita D TammaKaren C Carroll
Jan 13, 2009·Clinical Microbiology Reviews·George A Jacoby
Feb 26, 2010·Journal of Clinical Microbiology·Kenneth S Thomson
Jun 3, 2011·Journal of Clinical Microbiology·Silke PolsfussMichael Hombach
Aug 17, 2012·Journal of Clinical Microbiology·Chelsie N GeyerNancy D Hanson
Mar 19, 2013·The Pan African Medical Journal·Sasirekha BakthavatchaluTannu Mishra
Apr 29, 2011·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Miroslava Htoutou SedlakovaArne C Rodloff
Mar 20, 2014·PloS One·E Ascelijn ReulandNashwan al Naiemi
Oct 18, 2012·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Vendula HusickovaMilan Kolar
Mar 20, 2013·Indian Journal of Medical Microbiology·N O YilmazA Uzel
Aug 26, 2014·Jundishapur Journal of Microbiology·Mona WassefEmad Abada
Jun 20, 2014·Indian Journal of Pathology & Microbiology·Arindam ChakrabortyVishwas Saralaya
Mar 19, 2014·Future Medicinal Chemistry·Derek A NicholsYu Chen
Sep 30, 2014·Scandinavian Journal of Infectious Diseases·Lisa M BlanchetteMichael D Nailor
Dec 17, 2014·Expert Opinion on Pharmacotherapy·Abrar K ThabitDavid P Nicolau
Mar 18, 2011·American Journal of Clinical Pathology·Kenneth H RandAndrea Zimmer
Aug 13, 2009·Journal of Biomedicine & Biotechnology·King-Ting LimKwai-Lin Thong
Apr 18, 2015·Annals of Clinical Microbiology and Antimicrobials·Vera ManageiroManuela Caniça
Dec 4, 2014·The Journal of Antimicrobial Chemotherapy·Vanesa PascualEsther Calbo
Mar 15, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Hyunjoo PaiSung Hee Oh
Dec 20, 2008·International Journal of Antimicrobial Agents·Francesco LuzzaroAntonio Toniolo
Aug 24, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·V PascualE Calbo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.